BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Servier's Phase 3 INDIGO trial shows positive results for vorasidenib in IDH-mutant Glioma

Clinically meaningful achievement of primary and secondary endpoints is first major advance in treatment of low-grade glioma in more than 20 years Endpo...

March 15, 2023 | News

Antengene's ATG-022 Phase I CLINCH Trial for Solid Tumor Treatment Receives IND Approval in China

- Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Assoc...

March 14, 2023 | News

Telix's Revolutionary Kidney Cancer Imaging Study Takes Center Stage at EAU's 'Game Changing' Session

The results were featured in a "Game Changing" oral session delivered by Professor Dr. Peter Mulders from Radboud University Medical Centre (Neth...

March 14, 2023 | News

H1 Launches Advanced Diversity Insights and Clinical Trial Performance Insights

H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of indication-level ...

March 13, 2023 | News

Boan Biotech Completes Patient Enrollment for Aflibercept Trial in China

Aflibercept is a homodimeric fusion protein consisting of portions of human vascular endothelial growth factor receptor (VEGFR) extracellular domains (VEGF...

March 13, 2023 | News

AnnJi Pharma and Avenue Therapeutics Enter Licensing Agreement for Clinical Asset AJ201 to Treat Kennedy's Disease.

Under the terms of the license agreement, AnnJi will receive upfront payments of $3 million and is entitled to receive future development, regula...

March 13, 2023 | News

Estrella Biopharma's ARTEMIS® T Cell Therapy EB103 IND Cleared by FDA for B-Cell Lymphomas Clinical Trial

Estrella Biopharma, Inc. ("Estrella"), a biopharmaceutical company whose mission is to harness the evolutionary power of the human immune system to transfo...

March 09, 2023 | News

Telix to Present ZIRCON Phase III Kidney Cancer Imaging Data and Theranostic Pipeline at EAU

Further data from Telix's completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) (Clinic...

March 09, 2023 | News

Study finds plate choice can affect EM microbial air sampling accuracy and Annex 1 compliance

Cherwell, specialists in cleanroom microbiology solutions for the pharmaceutical, healthcare and related industries, has published the findings of an...

March 07, 2023 | News

Porton Advanced and DanausGT Collaborate on Gene and Cell Therapy Development.

As an end-to-end gene and cell therapy service provider, Porton Advanced CDMO offers comprehensive solutions covering plasmids, cell therapy, gene therapy,...

March 02, 2023 | News

Thermo Fisher Scientific’s Clinical Research Business Recognized by ISG for Digital Services Leadership

In its 2022 ISG Provider Lens™ Life Sciences Digital Services Global Report, ISG recognized Thermo Fisher’s clinical research business for...

February 27, 2023 | News

SERDA therapeutics submits IND for its lead product, an innovative wound debridement agent

SN514 hydrogel is a topical debridement product designed to remove eschar rapidly and effectively from severe burn wounds and chronic ulcers, including p...

February 24, 2023 | News

AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study

To date, the study has enrolled over 18,000 individuals from a general population of 230,000 persons located in China. The test subjects were tested ...

February 23, 2023 | News

Thermo Fisher Scientific Selected to Support National Institute of Health’s Blueprint MedTech program

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, has been awarded a five-year contract to provide ...

February 21, 2023 | News

Stay Connected